Annual EBITDA
-$1.83 M
-$1.80 M-5071.47%
December 1, 2023
Summary
- As of February 21, 2025, BLAC annual EBITDA is -$1.83 million, with the most recent change of -$1.80 million (-5071.47%) on December 1, 2023.
- BLAC annual EBITDA is now -55375.76% below its all-time high of -$3300.00, reached on December 1, 2021.
Performance
BLAC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$454.10 K
+$21.40 K+4.50%
September 1, 2024
Summary
- As of February 21, 2025, BLAC quarterly EBITDA is -$454.10 thousand, with the most recent change of +$21.40 thousand (+4.50%) on September 1, 2024.
- Over the past year, BLAC quarterly EBITDA has stayed the same.
- BLAC quarterly EBITDA is now -454000.00% below its all-time high of -$100.00, reached on September 1, 2021.
Performance
BLAC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$2.24 M
-$43.70 K-1.99%
September 1, 2024
Summary
- As of February 21, 2025, BLAC TTM EBITDA is -$2.24 million, with the most recent change of -$43.70 thousand (-1.99%) on September 1, 2024.
- Over the past year, BLAC TTM EBITDA has stayed the same.
- BLAC TTM EBITDA is now -149386.67% below its all-time high of -$1500.00, reached on June 1, 2022.
Performance
BLAC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BLAC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5071.5% | 0.0% | 0.0% |
| 3 y3 years | - | 0.0% | 0.0% |
| 5 y5 years | - | 0.0% | 0.0% |
BLAC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | <-9999.0% | +47.3% | <-9999.0% | at low |
| 5 y | 5-year | <-9999.0% | at low | <-9999.0% | +47.3% | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +47.3% | <-9999.0% | at low |
Bellevue Life Sciences Acquisition EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$454.10 K(-4.5%) | -$2.24 M(+2.0%) |
| Jun 2024 | - | -$475.50 K(+5.5%) | -$2.20 M(+9.7%) |
| Mar 2024 | - | -$450.80 K(-47.7%) | -$2.00 M(+9.4%) |
| Dec 2023 | -$1.83 M(+5071.5%) | -$861.90 K(+110.0%) | -$1.83 M(+86.2%) |
| Sep 2023 | - | -$410.40 K(+46.4%) | -$983.10 K(+65.9%) |
| Jun 2023 | - | -$280.30 K(+0.8%) | -$592.70 K(+89.1%) |
| Mar 2023 | - | -$278.10 K(+1844.8%) | -$313.40 K(+785.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$35.40 K(+972.7%) | -$14.30 K(-28.5%) | -$35.40 K(+65.4%) |
| Sep 2022 | - | -$20.00 K(+1900.0%) | -$21.40 K(+1326.7%) |
| Jun 2022 | - | -$1000.00(+900.0%) | -$1500.00(-53.1%) |
| Mar 2022 | - | -$100.00(-66.7%) | -$3200.00(+3.2%) |
| Dec 2021 | -$3300.00 | -$300.00(+200.0%) | -$3100.00(+10.7%) |
| Sep 2021 | - | -$100.00(-96.3%) | -$2800.00(+3.7%) |
| Jun 2021 | - | -$2700.00 | -$2700.00 |
FAQ
- What is Bellevue Life Sciences Acquisition annual EBITDA?
- What is the all time high annual EBITDA for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition annual EBITDA year-on-year change?
- What is Bellevue Life Sciences Acquisition quarterly EBITDA?
- What is the all time high quarterly EBITDA for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition quarterly EBITDA year-on-year change?
- What is Bellevue Life Sciences Acquisition TTM EBITDA?
- What is the all time high TTM EBITDA for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition TTM EBITDA year-on-year change?
What is Bellevue Life Sciences Acquisition annual EBITDA?
The current annual EBITDA of BLAC is -$1.83 M
What is the all time high annual EBITDA for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high annual EBITDA is -$3300.00
What is Bellevue Life Sciences Acquisition annual EBITDA year-on-year change?
Over the past year, BLAC annual EBITDA has changed by -$1.80 M (-5071.47%)
What is Bellevue Life Sciences Acquisition quarterly EBITDA?
The current quarterly EBITDA of BLAC is -$454.10 K
What is the all time high quarterly EBITDA for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high quarterly EBITDA is -$100.00
What is Bellevue Life Sciences Acquisition quarterly EBITDA year-on-year change?
Over the past year, BLAC quarterly EBITDA has changed by $0.00 (0.00%)
What is Bellevue Life Sciences Acquisition TTM EBITDA?
The current TTM EBITDA of BLAC is -$2.24 M
What is the all time high TTM EBITDA for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high TTM EBITDA is -$1500.00
What is Bellevue Life Sciences Acquisition TTM EBITDA year-on-year change?
Over the past year, BLAC TTM EBITDA has changed by $0.00 (0.00%)